Voltar
Artigo Acesso aberto Produção Nacional
BIBTEX RIS

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

2021; Linguagem: Inglês

10.1136/bmj.n2400

ISSN

1756-1833

Autores

Michelle Sholzberg, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle, Faris Alomran, Khalid Alayed, Mohammed AlSheef, Fahad AlSumait, Carlos Eduardo Pompílio, Catherine Sperlich, Sabrena Tangri, Terence Tang, Peter Jaksa, Deepa Suryanarayan, Mozah Almarshoodi, Lana A. Castellucci, Paula D. James, David Lillicrap, Marc Carrier, Andrew Beckett, Christos Colovos, Jai Jayakar, Marie‐Pier Arsenault, Cynthia Wu, Karine Doyon, Εleni Andreou, Vera Dounaevskaia, Eric Tseng, Gloria Lim, Michael Fralick, Saskia Middeldorp, Agnes Y.Y. Lee, Fei Zuo, Bruno R. da Costa, Kevin E. Thorpe, Elnara Márcia Negri, Mary Cushman, Peter Jüni,

Tópico(s)

Respiratory Support and Mechanisms

Resumo

To evaluate the effects of therapeutic heparin compared with prophylactic heparin among moderately ill patients with covid-19 admitted to hospital wards.

Referência(s)